Compass Therapeutics | IPO Presentation Deck | 40 slides · page 35 of 40
The slide shows dose-response curves for specific lysis of tumor cells, highlighting the potency of NKp30-based bispecifics.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 1/1 image 1/1 list 1/1 title 2/2
Components 5
line illustration bullet action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.